April 17, 2019
- Drugs@FDA Data Files (updated)
- FDA Drug Safety Podcast: FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering
- FDA Drug Shortages
- Bisoprolol Fumarate Tablets (Updated - Currently in Shortage)
- Buspirone HCl Tablets (Updated - Currently in Shortage)
- Carbidopa and Levodopa Extended Release Tablets (Updated - Currently in Shortage)
- Cycloserine Capsules, USP (Updated - Resolved)
- Dexrazoxane Injection (Updated - Currently in Shortage)
- Fludrocortisone Acetate Tablets (Updated - Currently in Shortage)
- Flurazepam Hydrochloride Capsules (Updated - Currently in Shortage)
- Fluvoxamine ER Capsules (Updated - Currently in Shortage)
- Guanfacine Hydrochloride Tablets (Updated - Currently in Shortage)
- Haloperidol Tablets (Updated - Currently in Shortage)
- Levetiracetam Immediate-Release Oral Tablets, USP (Updated - Currently in Shortage)
- Methyldopa Tablets (Updated - Currently in Shortage)
- Olmesartan Medoxomil Tablets (Updated - Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage)
- Progesterone Injection, USP (Updated - Currently in Shortage)
- Sterile Talc Powder (Updated - Currently in Shortage)
- Thioridazine Hydrochloride Tablets (Updated - Currently in Shortage)
- Thiothixene Capsules (Updated - Currently in Shortage)
- Timolol Maleate Tablets (Updated - Currently in Shortage)
- Trifluoperazine Hydrochloride Tablets (Updated - Currently in Shortage)
.png)
No hay comentarios:
Publicar un comentario